Onepot AI raises $13M to help make chemical drug creation easier

Share via:


For Daniil Boiko and Andrei Tyrin, the idea for Onepot AI came from the same frustration.  

“The best ideas in drug discovery were often blocked not by biology, but by synthesis,” Boiko told TechCrunch. Synthesis is the creation of new molecules by using chemical reactions. It’s like a recipe or Lego pieces, where small pieces, ingredients, molecules, come together to form a wider puzzle picture, a food dish, a larger molecule.  

As one might expect, it’s quite hard to create those small molecules that go on to…



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Popular

More Like this

Onepot AI raises $13M to help make chemical drug creation easier


For Daniil Boiko and Andrei Tyrin, the idea for Onepot AI came from the same frustration.  

“The best ideas in drug discovery were often blocked not by biology, but by synthesis,” Boiko told TechCrunch. Synthesis is the creation of new molecules by using chemical reactions. It’s like a recipe or Lego pieces, where small pieces, ingredients, molecules, come together to form a wider puzzle picture, a food dish, a larger molecule.  

As one might expect, it’s quite hard to create those small molecules that go on to…



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi

More like this

Paytm sets up units in Indonesia, Luxembourg; sells 49%...

One97 Communications Ltd, the parent company of fintech...

Apple reiterates long-term commitment to China

In a meeting with Li Chenggang, China’s International...

Why AI Agents Are ‘Just Another Backend’

In 2014, asking companies why they’d want to...

Popular